BP000036-GD10: Recombinant Human FVII Protein
Source: HEK 293 cell derived.
Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
Purity > 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.BP000036-GD11: Recombinant Human FVIIa Protein
Source: 293 cell derived.
The potency per mg of recombinant human FVIIa protein was tested and found to be 50,000 Units/mg.
Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
Purity > 95%, by SDS-PAGE under reducing conditions.BP000037-GD12: Recombinant Human FVIII Protein
Source: 293 cell-derived
The potency per mg of recombinant human FVIII protein was tested and found to be 11,000 Units/mg.
Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
Purity > 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.BP000051-GD14: Recombinant Human OPG-Fc Fusion Protein
Source: HEK 293-derived.
The Osteoprotegerin / OPG / TNFRSF11B / OCIF / OBF activity is calculated by its ability to inhibit TRAIL-mediated cytotoxicity using L929 mouse fibrosarcoma cells treated with TRAIL. The ED50 for this effect is typically 5 ng/ml.
Endotoxin: < 5.0 EU per 1 ug of the protein by the LAL method.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000339-GD15: Recombinant Human Chorionic Gonadotropin (hCG)
Source: CHO-derived.
The hCG α/β activity was determined to be 25,000 IU/mg.
Purity > 97% by SDS-PAGE under reducing conditions and visualized by silver stain, and 97% by SEC-HPLC.BP002388-Z53: Recombinant Human Cellular tumor antigen p53 (p53) Protein
Source: Baculovirus, SF9 insect cells-derived.
Bioactivity test: 1 unit equals 1 nanogram of purified protein. 10 unit is sufficient for a gel mobility shift assay in a 20 ul reaction; 50 units are sufficient for reconstituted transcription assay and 100 units are sufficient for a protein-protein interaction assay.
Purity: > 95%, by SDS-PAGE.
Endotoxin Level: < 1.0 EU per 1 ug of the protein by the LAL method.BP000027-GD1: Recombinant Human VEGF165 (aa 27-191) Protein
Source: HEK 293 cell-derived.
The VEGF activity is measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 1-5 ng/ml.
Endotoxin: < 1.0 EU per ug of the protein by the LAL method.
Purity: > 95% by SDS-PAGE under reducing conditions.BP000035-GD9: Recombinant Human FSH α/β Protein
Source: CHO cell-derived.
The FSH α/β activity is measured in a human FSH receptor transfected HEK 293 cells. The ED50 for this effect is 0.1-0.4 ng/ml.
Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
Purity > 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.BP000050-GD13: Recombinant Human RANKL Protein
Source:E. coli-derived.
The RANKL / TNFSF11 / TRANCE / OPGL / CD254 activity is calculated by its ability to induce osteoclast differentiation on RAW 264.7 mouse macrophages. The ED50 for this effect is 2-12 ng/ml.
Endotoxin Level: <1.0 EU per ug of the protein by the LAL method.
Purity > 95%, by SDS-PAGE and SEC-HPLC.BP001573-K0104: Recombinant Human PAK1 Kinase Domain (PAK1KD) Enzyme
Source: E. coli-derived.
Specific activity: 32,638 pmoles/min/ug. Analysis of enzymatic activity was performed according to the Zlyte assay protocol (Invitrogen).
Applications: Enzymatic studies, inhibitor screen, and selectivity profiling; High concentration available for crystallization.